These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 12104059

  • 1. A pharmacoeconomic evaluation of results from the Coronary Angioplasty Amlodipine Restenosis Study (CAPARES) in Norway and Canada.
    Thaulow E, Jorgensen B, Doyle JJ, Casciano R, Casciano J, Kopp Z, Arikian S, Kim R.
    Int J Cardiol; 2002 Jul; 84(1):23-30; discussion 30-2. PubMed ID: 12104059
    [Abstract] [Full Text] [Related]

  • 2. Pharmacoeconomic consequences of amlodipine besylate therapy in patients undergoing PTCA.
    Rossetti F, De Portu S, Menditto E, Scalone L, Bustacchini S, Cricelli C, Mantovani LG.
    Pharmacol Res; 2006 Mar; 53(3):197-201. PubMed ID: 16406672
    [Abstract] [Full Text] [Related]

  • 3. Restenosis and clinical outcome in patients treated with amlodipine after angioplasty: results from the Coronary AngioPlasty Amlodipine REStenosis Study (CAPARES).
    Jørgensen B, Simonsen S, Endresen K, Forfang K, Vatne K, Hansen J, Webb J, Buller C, Goulet G, Erikssen J, Thaulow E.
    J Am Coll Cardiol; 2000 Mar 01; 35(3):592-9. PubMed ID: 10716459
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Results and clinical implications of the CAPARES trial.
    Thaulow E, Jorgensen B.
    Can J Cardiol; 2000 Jul 01; 16 Suppl D():8D-11D. PubMed ID: 10932030
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. An updated meta-analysis of calcium-channel blockers in the prevention of restenosis after coronary angioplasty.
    Dens J, Desmet W, Piessens J.
    Am Heart J; 2003 Mar 01; 145(3):404-8. PubMed ID: 12660661
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cost analysis of amlodipine versus enalapril in patients with coronary artery disease and normal blood pressure: findings from the CAMELOT economic substudy.
    Menzin J, Boulanger L, Tang S, Thakker K, Nissen SE.
    Appl Health Econ Health Policy; 2008 Mar 01; 6(2-3):157-62. PubMed ID: 19231908
    [Abstract] [Full Text] [Related]

  • 17. Long-term results of RITA-1 trial: clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting. Randomised Intervention Treatment of Angina.
    Henderson RA, Pocock SJ, Sharp SJ, Nanchahal K, Sculpher MJ, Buxton MJ, Hampton JR.
    Lancet; 1998 Oct 31; 352(9138):1419-25. PubMed ID: 9807988
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Coronary artery bypass grafting (CABG) after initially successful percutaneous transluminal coronary angioplasty (PTCA): a review of 17 years experience.
    Barakate MS, Hemli JM, Hughes CF, Bannon PG, Horton MD.
    Eur J Cardiothorac Surg; 2003 Feb 31; 23(2):179-86. PubMed ID: 12559340
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.